We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for health professionals on tick-borne encephalitis (TBE) including symptoms, diagnosis and epidemiology.
How to spot equine viral encephalomyelitis, what to do if you suspect it and how to prevent it spreading.
You must tell DVLA if you have a brain abscess, cyst or encephalitis - download the correct form to let them know
Tick-borne encephalitis immunisation information for public health professionals, including updates.
Clinical advice on West Nile virus including symptoms, diagnosis and epidemiology.
Japanese encephalitis immunisation information for public health professionals.
Qualitative assessment of the risk that tick-borne encephalitis (TBE) virus presents to the UK human population.
The epidemiology, symptoms, diagnosis and management of Nipah virus infections.
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
A new risk assessment, published by a multi-agency cross-government committee, reports that tick borne encephalitis is now likely to be present in England.
Notifications of infectious diseases (NOIDs) and reportable causative organisms: legal duties of laboratories and medical practitioners.
Qualitative assessment of the risk that variegated squirrel Bornavirus presents to the UK population.
Monitoring for encephalitis should continue for 12 months following discontinuation of daclizumab. Inform all patients who have discontinued daclizumab and their caregivers of the common symptoms of encephalitis and the need to contact their doctor immediately if they occur.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.